
Advisory Council Releases Updates on Alzheimer Disease Treatments, Research
The Advisory Council on Alzheimer’s Research provided updates on Alzheimer Disease (AD) and AD and related dementias (ADRD) treatments and ongoing research in a virtual meeting. New treatments for AD, such as Leqembi and donanemab, were discussed. Biogen Inc. discontinued Aduhelm in favor of prioritizing lecanemab. Resources for dementia caregivers have increased, including a public…